Ex vivo generation of platelet products from human iPS cells
Abstract Platelet products are used in treatments for thrombocytopenia caused by hematopoietic diseases, chemotherapy, massive hemorrhages, extracorporeal circulation, and others. Their manufacturing depends on volunteers who donate blood. However, it is becoming increasingly necessary to reinforce...
Saved in:
Main Authors: | Sou Nakamura (Author), Naoshi Sugimoto (Author), Koji Eto (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2020-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Generation of Induced Pluripotent Stem (iPS) Cells by Nuclear Reprogramming
by: Dilip Dey, et al.
Published: (2011) -
iPS Cells for Modelling and Treatment of Human Diseases
Published: (2015) -
Quantitative analysis of intraneuronal transport in human iPS neurons
by: Haruko Nakamura, et al.
Published: (2015) -
Ex Vivo Generated Red Cells as Transfusion Products
by: Anna Rita Migliaccio, et al.
Published: (2012) -
The Promise and Therapeutic Potential of Human ES and iPS Cells
by: Shi-Jiang Lu, et al.
Published: (2011)